Published in Gene Therapy Weekly, August 22nd, 2002
Dausch has more than 30 years of experience in financial and operations management, most recently as executive vice president and chief operating officer for a publicly held biopharmaceutical company, where he also led its successful initial and follow-on public offerings as CFO.
"Rod brings with him an outstanding record of achievements in senior finance and administration positions at both private and publicly held biotechnology companies," said Nicholas C. Nicolaides, president and CEO. "His extensive operational skills and business networks will bring...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.